What happened
NSTS Bancorp, Inc. (NASDAQ: NSTS) completed its merger with Brookfield Bancshares, Inc. at 12:01 a.m. Eastern time on October 1, 2026. Each common share converted into the right to receive $14.31. Each restricted share and stock option under the 2023 equity plan vested when the merger took effect.
The option cash payment equals the difference between the exercise price and the per-share merger consideration. NSTS said its separate existence ended after the second merger. North Shore Trust and Savings became a wholly owned subsidiary of Brookfield.
The common stock will no longer be listed or traded on Nasdaq. At the special meeting on September 29, 2026, 3,765,965 shares were present or represented by proxy. That was 71.69% of shares outstanding and entitled to vote. Proposal 1 received 3,762,060 votes for and 3,905 against. Proposal 2 received 3,751,947 votes for and 14,018 against.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Per-share merger consideration | $14.31 per share | SEC 8-K | |
| Aggregate merger consideration | $73.66 million | SEC 8-K | |
| Shares present or represented by proxy | 3,765,965 shares | SEC 8-K | |
| Shares outstanding represented | 71.69% | SEC 8-K | |
| Votes for Proposal 1 | 3,762,060 votes | SEC 8-K | |
| Votes against Proposal 1 | 3,905 votes | SEC 8-K |
Read more: NSTS Bancorp (NSTS) stock analysis and investment case
Why it matters
OptimistFi's case on NSTS was that the stock depended less on sales growth than on whether management could turn excess capital and liquidity into durable earning power or shareholder returns. This filing changes that view. The equity now has a fixed cash value and no longer represents a standalone public thrift. The bank remains in place under Brookfield, even as the listed equity disappears.
The merger consideration totals $73.66 million across common stock, restricted stock and stock options. On Proposal 1, 99.90% of votes cast were in favor, based on 3,762,060 votes for and 3,905 against. That points to orderly approval, but the filing does not judge the $14.31 price.
Browse: stock research on every company OptimistFi covers
What's next
Brookfield Bancshares, Inc., as successor, said it plans to file Form 15 with the SEC to deregister the common stock under Section 12(g) and suspend reporting under Section 15(d). If that filing is made, NSTS's public-company reporting trail will wind down, and the standalone equity story will end. That would weaken any remaining turnaround case, because NSTS would no longer be a public company.
More from OptimistFi
- NSTS stock: the NSTS Bancorp thesis, its status and the next test to watch
- Broadcom Inc. (NASDAQ: AVGO) Has a $42 Billion Anthropic Test
- Autonomix Medical, Inc. (NASDAQ: AMIX) Gets a Clearer FDA Path
- FactSet Research Systems Inc. (NYSE: FDS) Guides to Slower ASV Growth
- Stock research on every company OptimistFi covers
- Latest stock research and investment-case updates
- OptimistFi: evidence-first equity research
Sources
- SEC 8-K — Current report filed Oct. 1, 2026, announcing the merger closing, the per-share consideration, the vote and the planned delisting and Form 15 filing.
Read the full OptimistFi thesis on NSTS Bancorp, Inc.: https://optimistfi.com/stocks/NSTS
See what would break the NSTS Bancorp, Inc. thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full NSTS Bancorp, Inc. investment case, its status and the next test to watch live on the NSTS Bancorp, Inc. thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
